SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-002693
Filing Date
2019-04-29
Accepted
2019-04-29 16:50:18
Documents
4
Period of Report
2019-06-11
Effectiveness Date
2019-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2238647zdef14a.htm DEF 14A 776202
2 G301614.JPG g301614.jpg GRAPHIC 26870
3 G27202BII001.JPG g27202bii001.jpg GRAPHIC 126274
4 G27202BII002.JPG g27202bii002.jpg GRAPHIC 120893
  Complete submission text file 0001047469-19-002693.txt   1155083
Mailing Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104
Business Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35890 | Film No.: 19776672
SIC: 2834 Pharmaceutical Preparations